Insufficient scRNA-seq data for expression of CYP2C19 at single-cell level.
Insufficient scRNA-seq data for expression of CYP2C19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2893.58 | 226 / 226 | 50% | 2.97 | 202 / 406 |
stomach | 70% | 341.82 | 251 / 359 | 14% | 0.33 | 41 / 286 |
esophagus | 38% | 121.43 | 556 / 1445 | 25% | 0.48 | 45 / 183 |
skin | 51% | 32.74 | 928 / 1809 | 0% | 0 | 0 / 472 |
intestine | 38% | 181.43 | 371 / 966 | 9% | 0.22 | 46 / 527 |
pancreas | 5% | 2.87 | 15 / 328 | 20% | 0.53 | 35 / 178 |
lung | 5% | 1.79 | 27 / 578 | 5% | 0.12 | 54 / 1155 |
bladder | 5% | 1.95 | 1 / 21 | 2% | 0.02 | 10 / 504 |
uterus | 1% | 1.96 | 2 / 170 | 4% | 0.15 | 17 / 459 |
kidney | 3% | 1.06 | 3 / 89 | 1% | 0.01 | 5 / 901 |
peripheral blood | 3% | 3.40 | 29 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
breast | 1% | 0.61 | 5 / 459 | 0% | 0.00 | 1 / 1118 |
adipose | 1% | 0.37 | 10 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0.15 | 11 / 2642 | 0% | 0 | 0 / 705 |
spleen | 0% | 1.25 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.05 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.06 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.02 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0016098 | Biological process | monoterpenoid metabolic process |
GO_0097267 | Biological process | omega-hydroxylase P450 pathway |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0019899 | Molecular function | enzyme binding |
GO_0018675 | Molecular function | (S)-limonene 6-monooxygenase activity |
GO_0070330 | Molecular function | aromatase activity |
GO_0052741 | Molecular function | (R)-limonene 6-monooxygenase activity |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO_0120319 | Molecular function | long-chain fatty acid omega-1 hydroxylase activity |
GO_0019825 | Molecular function | oxygen binding |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0018676 | Molecular function | (S)-limonene 7-monooxygenase activity |
GO_0008392 | Molecular function | arachidonic acid epoxygenase activity |
GO_0008395 | Molecular function | steroid hydroxylase activity |
Gene name | CYP2C19 |
Protein name | Cytochrome P450 Cytochrome P450 family 2 subfamily C polypeptide 19 Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase) Cytochrome P450 family 2 subfamily C member 19 |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of polyunsaturated fatty acids (PUFA) . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) . Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates PUFA specifically at the omega-1 position . Catalyzes the epoxidation of double bonds of PUFA . Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol . Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine. Hydroxylates fenbendazole at the 4' position . . |
Accessions | B0ZDM8 ENST00000480405.2 A0A087X125 A0A2D1BPP2 A0A2D1BII0 Q767A3 P33261 ENST00000371321.9 |